美国Seracare HIV血清线性盘（HIV Linearity Panels）

广州健仑生物科技有限公司

SeraCare Life Sciences公司主要在美国、欧洲和亚洲提供促进人类和动物诊断和治疗学的探索、开发和生产的产品和服务。其业务分为两个部分：诊断和生物制药产品和生物服务。诊断和生物制药产品部门生产和销售诊断和控制面板产品，用于测试传染性疾病的临床实验室及员工培训和能力测试。生物服务部门提供生物银行、来样加工和测试服务。

美国SeraCare收购BBI公司，即原BBI血清盘已经改名为SeraCare血清盘。

其产品包括有：传染病阳性质控品、疾病标准品、细菌阳性质控品、人血清白蛋白、人伽马球蛋白、牛血清白蛋白、血清盘、人血浆、人血清。

SeraCare的血清盘包括：HIV-1转化盘、HIV性能盘、HBV转化盘、HBV性能盘、HCV转化盘、HCV性能盘、弓形虫性能盘、线性盘和质控盘等等。

我司还提供其它进口或国产试剂盒：登革热、疟疾、流感、A链球菌、合胞病毒、腮病毒、乙脑、寨卡、黄热病、基孔肯雅热、克锥虫病、违禁品滥用、肺炎球菌、军团菌、化妆品检测、食品安全检测等试剂盒以及日本生研细菌分型诊断血清、德国SiFin诊断血清、丹麦SSI诊断血清等产品。

欢迎咨询

欢迎咨询2042552662

美国Seracare HIV血清线性盘（HIV Linearity Panels）

美国Seracare

想了解更多的产品及服务请扫描下方二维码：

【公司名称】 广州健仑生物科技有限公司

【市 场 部】    杨永汉

【】 

【腾讯Q Q】 2042552662

【公司地址】 广州清华科技园创新基地番禺石楼镇创启路63号二期2幢101-103室

“我们曾经推测，异质性可以通过细胞间的mtDNA交换稳定下来，”Sachidanandam说。“结果显示，mtDNA交换的确可行，异质性能够通过这一机制维持稳定。这一技术为人们提供了一个新平台，可以研究正常和疾病状态下mtDNA异质性特征。未来也许可以利用交换机制进行治疗，将坏mtDNA换成好mtDNA。”
随着测序技术的发展，宏基因组学逐渐成为了新的热门领域。宏基因组学主要是鉴定环境样本中的所有微生物，理解它们各自所起的作用。这类研究比一般的基因组分析更需要计算机技术的帮助，因为宏基因组学研究的是不同基因组的混合物。
近日，东安格利亚大学研究人员通过血液稀释剂对人体艾滋病毒天然屏障有了新了解。
新研究揭示了朗格汉斯蛋白如何作为感染艾滋病毒*阶段的自然屏障存在于生殖器分泌液中，期间与药物肝素相互作用。
研究小组已经鉴定了朗格汉斯蛋白和肝素之间不同机制的相互作用。东安格利亚大学药学学院博士研究员Jesus Angulo说：“朗格汉斯蛋白存在于生殖器粘液中并由免疫细胞产生。艾滋病病毒在感染人的过程中朗格汉斯蛋白组成了*道屏障。肝素是一种抗凝剂，用来防止血栓的形成。但它也在体内自然生成，并且带有不同成分包绕着我们的细胞。”
“朗格汉斯蛋白与肝素的交互作用对hiv病毒退化来说是非常重要的。肝素与朗格汉斯蛋白交互的方式很重要，因为它被认为可以稳定颗粒的形成，有利于消除艾滋病毒颗粒。”
“这是一个基本的研究，该研究提供了一个已知HIV天然屏障潜在交互作用的细节结构。然而，这并不意味着服用肝素或其他抗凝药物会保护人们免受艾滋病毒的侵扰。”
“这一研究的zui终目的是开发抑制促感染艾滋病毒细胞受体的药物，该药并能促进朗格汉斯蛋白活性。抗艾滋药物的研制显然是一个长期目标，而该研究提供了重要的制药初始步骤。”

"We once speculated that heterogeneity can be stabilized by the exchange of mtDNA between cells," said Sachidanandam. "The results show that mtDNA exchange is indeed feasible and that heterogeneity can be maintained through this mechanism. This technology provides people with a new platform to study mtDNA heterogeneity under normal and disease conditions. In the future, it may be possible to use exchange mechanisms. For treatment, replace bad mtDNA with good mtDNA."
With the development of sequencing technology, metagenomics has gradually become a new hot area. Metagenomics is mainly to identify all microorganisms in an environmental sample and understand their respective roles. This type of research requires more computer technology than generic genomics because metagenomics studies a mixture of different genomes.
Recently, researchers at the University of East Anglia have gained new insights into the natural barriers to human HIV through blood thinners.
The new study revealed how Langerhans proteins exist as a natural barrier to HIV infection in genital exudates, interacting with the drug heparin.
The team has identified different mechanisms of interaction between the Langerhans protein and heparin. According to Jesus Angulo, a Ph.D. researcher at the Faculty of Pharmacy at the University of East Anglia, “The Langerhans protein is present in the genital mucus and is produced by immune cells. The AIDS virus infects humans and the Langerhans proteins form the first barrier. Heparin is an anticoagulant used to prevent the formation of blood clots, but it is also naturally produced in the body and has different components that surround our cells."
“The interaction of the Langerhans protein and heparin is important for the degradation of the HIV virus. The way heparin interacts with the Langerhans protein is important because it is thought to stabilize the formation of particles and help eliminate HIV. Particles."
"This is a basic study that provides a detailed structure of potential interactions known to be the natural barrier to HIV. However, this does not mean that taking heparin or other anticoagulants will protect people from HIV."
"The ultimate goal of this study is to develop drugs that inhibit the receptors for HIV-infected cells, which can also contribute to Langerhans protein activity. The development of anti-HIV drugs is clearly a long-term goal, and the study provides important Pharmaceutical initial steps."